Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma
Weiren Liu(Fudan University), Ying–Hong Shi(Ministry of Education of the People's Republic of China), Huqiang Wang(Beijing Proteome Research Center), Qianfu Zhao(Sun Yat-sen University), Gui‐Qi Zhu(Ministry of Education of the People's Republic of China), Jian Zhou(Shenzhen University Health Science Center), Chenyang Tao(Ministry of Education of the People's Republic of China), Yushan Hou(Beijing Proteome Research Center), Zhixiang Yang(Beijing Proteome Research Center), Rui Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jia Fan(Nanjing Tech University), Jiafeng Chen(Quzhou University), Jun Gao(Inner Mongolia Medical University), Zheng Tang(Ministry of Education of the People's Republic of China), Xiaoling Wu(Shanghai Medical College of Fudan University), Run Huang(Ministry of Education of the People's Republic of China), Yuan Fang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dong Yang(Beijing Proteome Research Center), Rongyu Ping(Chinese PLA General Hospital), Xi‐Fei Jiang(Sun Yat-sen University), Wei‐Feng Qu(Ministry of Education of the People's Republic of China), Zimei Sun(Beijing Proteome Research Center), Tianhao Chu(Peking University)
Cited by 17
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828